Several US-listed XRP exchange-traded funds outperformed XRP's own price rally by roughly 100% on September 3, 2026, as the token climbed 7-8% intraday to near $1.44 while three smaller funds posted gains close to double that. The imbalance appears less a sign of fresh institutional demand and more a thin-liquidity distortion in US order books.

The divergence cuts both ways. Bulls can read the ETF surge as evidence of strong buy-side appetite for regulated XRP exposure, while skeptics note the gap emerged without any new capital entering the products, pointing to a mechanical premium rather than a durable conviction trade.

XRP ETFs Pull Far Ahead of the Token

On September 3, three of the seven US spot XRP ETFs delivered outsized moves: Grayscale's XXRP rose +17.10%, UXRP gained +17.01%, and XRPT added 16.78% during the session. The underlying XRP token, by contrast, moved only 7-8% intraday, leaving the funds ahead by close to double.

ETF vs Token — Sep 3, 2026:

• Grayscale XXRP: +17.10%
• UXRP ETF: +17.01%
• XRP Token: ~+8%

Nasdaq-listed ETFs outpaced the underlying token by ~100%. Source: U.Today

Not every fund diverged. The two largest by profile tracked the token closely, with the Bitwise XRP ETF up +8.47% and Franklin Templeton's XRPZ up +8.36% on the same day, roughly in line with spot. All seven US spot XRP ETFs finished the session in the green simultaneously.

The split maps cleanly onto listing venue. The three outperformers — XXRP, UXRP and XRPT — are Nasdaq-listed, while the two that tracked spot, Bitwise and Franklin Templeton, trade on the NYSE. That points to exchange-level liquidity differences as a structural driver rather than any XRP-specific catalyst.

Why Thin Order Books Can Push ETF Prices Above the Token

The available data does not describe these as leveraged 2x or 3x products. Instead, the divergence is attributed to a NAV premium, in which an ETF's share price temporarily trades above the net asset value of the XRP it holds. The distinction matters: a premium is a pricing gap, not compounded leverage.

Under normal conditions, ETF premiums are self-correcting: authorized participants can create new fund shares to capture the gap, which adds supply and pulls the price back toward NAV. When a fund's order book is thin, however, that arbitrage channel works more slowly, and even modest buy-side pressure can hold prices well above the underlying asset for extended stretches of the session.

CryptoQuant analyst Xaif_Crypto, who first flagged the anomaly on X, said the divergence was likely linked to a local supply-and-demand distortion in US exchange order books, where aggressive buy orders met thin sell-side depth in the smaller funds and pushed share prices above NAV.

Flow data supports the mechanical reading over a demand narrative. No fresh capital drove the surge: the previous session logged $7.20 million in net outflows, concentrated entirely in Bitwise's product, while every other issuer recorded zero flows.

That is the counterintuitive core of the event. Share prices in the smaller funds rallied hardest even as the sector as a whole saw money leaving — a retail-demand-meets-institutional-exit dynamic rather than a broad rotation into XRP ETFs. Premiums built on thin liquidity can widen fast and unwind just as fast, so the same distortion that inflated returns on the way up carries reversal risk if buy pressure fades.

What the Imbalance Signals for XRP Market Structure

The scale of institutional exposure remains modest. US spot XRP ETFs collectively hold $1.42 billion in assets under management, equal to about 1.67% of XRP's total market cap, with cumulative net inflows since launch exceeding $1.68 billion. That footprint is small relative to the spot Bitcoin ETF market, where US-listed products have accumulated hundreds of billions in assets since their January 2024 debut — a comparison that frames how early the XRP ETF category still is.

US Spot XRP ETF — Total AUM: $1.42B, approximately 1.67% of XRP's total market cap. Source: U.Today

Trading was similarly light. Total daily US XRP ETF volume on the session reached just $27.22 million, of which $19.7 million came during intraday trading — a thin base that helps explain how buy pressure could overwhelm sell-side depth in the smaller products.

The XRP ETF category itself was made possible by regulatory clarity following Ripple's legal resolution with the SEC, and continued institutional interest in the space has coincided with broader pressure from crypto firms pushing the SEC to speed up ETF reviews. No new regulatory action is tied to this specific imbalance.

For the underlying token, the September 3 move was a recovery from XRP's August 2026 low of $1.00. As of September 5, XRP trades at $1.40 with an $87.70 billion market cap and $2.80 billion in 24-hour volume, down 3.34% on the day as the surge cooled, according to CoinGecko. XRP had recently featured among the majors when lower Fed hike odds lifted risk assets.

Sentiment across the wider market sits at 73 on the Fear & Greed Index, a "Greed" reading that has coincided with elevated institutional positioning, including prior disclosures of XRP ETF exposure at firms such as Goldman Sachs and Morgan Stanley. That same greed backdrop has accompanied recent rallies in which dovish Fed signals lifted XRP alongside Ethereum and Dogecoin.

The bull case: if the ETF premium reflects genuine demand outrunning available supply, it argues for deeper appetite than the modest AUM suggests, and a widening product landscape could absorb more of it. The bear case: with outflows on the prior session and volumes under $30 million, the premium looks like a liquidity artifact that ETF buyers could see reverse sharply, leaving them worse off than spot holders. Whether the gap narrows on subsequent sessions — and how quickly authorized participants step in to arbitrage it — is the concrete signal to watch.

Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Cryptocurrency and digital asset markets carry significant risk. Always do your own research before making decisions.